JP2016510763A5 - - Google Patents

Download PDF

Info

Publication number
JP2016510763A5
JP2016510763A5 JP2015561740A JP2015561740A JP2016510763A5 JP 2016510763 A5 JP2016510763 A5 JP 2016510763A5 JP 2015561740 A JP2015561740 A JP 2015561740A JP 2015561740 A JP2015561740 A JP 2015561740A JP 2016510763 A5 JP2016510763 A5 JP 2016510763A5
Authority
JP
Japan
Prior art keywords
seq
polypeptide
amino acid
acid sequence
sequence selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015561740A
Other languages
English (en)
Japanese (ja)
Other versions
JP6567429B2 (ja
JP2016510763A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/022102 external-priority patent/WO2014138687A1/en
Publication of JP2016510763A publication Critical patent/JP2016510763A/ja
Publication of JP2016510763A5 publication Critical patent/JP2016510763A5/ja
Priority to JP2019140222A priority Critical patent/JP6918871B2/ja
Application granted granted Critical
Publication of JP6567429B2 publication Critical patent/JP6567429B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015561740A 2013-03-08 2014-03-07 関節損傷の治療のためのペプチドおよび組成物 Active JP6567429B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2019140222A JP6918871B2 (ja) 2013-03-08 2019-07-30 関節損傷の治療のためのペプチドおよび組成物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361775400P 2013-03-08 2013-03-08
US61/775,400 2013-03-08
US201461938123P 2014-02-10 2014-02-10
US61/938,123 2014-02-10
PCT/US2014/022102 WO2014138687A1 (en) 2013-03-08 2014-03-07 Peptides and compositions for treatment of joint damage

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019140222A Division JP6918871B2 (ja) 2013-03-08 2019-07-30 関節損傷の治療のためのペプチドおよび組成物

Publications (3)

Publication Number Publication Date
JP2016510763A JP2016510763A (ja) 2016-04-11
JP2016510763A5 true JP2016510763A5 (enExample) 2017-04-13
JP6567429B2 JP6567429B2 (ja) 2019-08-28

Family

ID=50390286

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2015561740A Active JP6567429B2 (ja) 2013-03-08 2014-03-07 関節損傷の治療のためのペプチドおよび組成物
JP2019140222A Active JP6918871B2 (ja) 2013-03-08 2019-07-30 関節損傷の治療のためのペプチドおよび組成物
JP2021119517A Pending JP2021178841A (ja) 2013-03-08 2021-07-20 関節損傷の治療のためのペプチドおよび組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2019140222A Active JP6918871B2 (ja) 2013-03-08 2019-07-30 関節損傷の治療のためのペプチドおよび組成物
JP2021119517A Pending JP2021178841A (ja) 2013-03-08 2021-07-20 関節損傷の治療のためのペプチドおよび組成物

Country Status (38)

Country Link
US (4) US9649359B2 (enExample)
EP (2) EP3391900B1 (enExample)
JP (3) JP6567429B2 (enExample)
KR (1) KR102267341B1 (enExample)
CN (2) CN111808182A (enExample)
AP (1) AP2015008675A0 (enExample)
AU (3) AU2014225348B2 (enExample)
BR (2) BR122016021558B1 (enExample)
CA (1) CA2903448C (enExample)
CL (1) CL2015002443A1 (enExample)
CO (1) CO7461145A2 (enExample)
CR (2) CR20200290A (enExample)
CU (1) CU24301B1 (enExample)
CY (1) CY1120729T1 (enExample)
DK (1) DK2964250T3 (enExample)
EA (1) EA035158B1 (enExample)
EC (1) ECSP15042898A (enExample)
ES (1) ES2684349T3 (enExample)
HR (1) HRP20181269T1 (enExample)
HU (1) HUE038499T2 (enExample)
IL (1) IL240727B (enExample)
JO (1) JO3564B1 (enExample)
LT (1) LT2964250T (enExample)
MX (1) MX365157B (enExample)
MY (1) MY173172A (enExample)
NZ (1) NZ711037A (enExample)
PE (1) PE20151528A1 (enExample)
PH (1) PH12015501983B1 (enExample)
PL (1) PL2964250T3 (enExample)
PT (1) PT2964250T (enExample)
RS (1) RS57446B1 (enExample)
SG (1) SG11201506490TA (enExample)
SI (1) SI2964250T1 (enExample)
TN (1) TN2015000385A1 (enExample)
TW (1) TWI634124B (enExample)
UY (1) UY35368A (enExample)
WO (1) WO2014138687A1 (enExample)
ZA (1) ZA201505966B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20160507A1 (es) 2009-07-14 2016-05-20 Scripps Research Inst Diferenciacion de celulas madre mesenquimales
US9301971B2 (en) 2013-03-08 2016-04-05 Novartis Ag Peptides and compositions for treatment of joint damage
UY35368A (es) 2013-03-08 2014-10-31 Irm Llc Péptidos y composiciones para el tratamiento de daño articular
CN109891632A (zh) 2016-10-24 2019-06-14 住友化学株式会社 间隔件、和包含间隔件的二次电池
AU2017358282C1 (en) * 2016-11-09 2020-11-26 Icm Co., Ltd. Nkx3.2 fragment and pharmaceutical composition comprising same as active ingredient
CN109963579A (zh) * 2016-11-14 2019-07-02 诺华股份有限公司 用于治疗软骨损伤和关节炎的方法和组合物
CN108530619B (zh) * 2017-03-01 2020-12-08 北京大学第三医院 功能化氨基酸、制备方法及由其制得的功能化氨基酸水凝胶
JOP20190245A1 (ar) 2017-04-20 2019-10-15 Novartis Ag أنظمة توصيل إطلاق مستدام تتضمن روابط بلا أثر لنقطة الربط
US12168012B2 (en) 2018-07-25 2024-12-17 Novartis Ag NLRP3 inflammasome inhibitors
TW202027794A (zh) * 2018-10-03 2020-08-01 瑞士商諾華公司 血管生成素樣３多肽之持續遞送
AR119731A1 (es) 2019-05-17 2022-01-05 Novartis Ag Inhibidores del inflamasoma nlrp3
US20220380425A1 (en) * 2019-07-04 2022-12-01 Cadila Healthcare Limited Angptl3 based vaccine for the treatment of liver disease
KR102577697B1 (ko) * 2019-11-13 2023-09-14 주식회사 나이벡 염증 및 상처 치료용 펩타이드
JP7298496B2 (ja) 2020-01-31 2023-06-27 トヨタ自動車株式会社 車両
TW202306970A (zh) 2021-05-24 2023-02-16 瑞士商諾華公司 用於治療骨關節炎之方法
CN117355323A (zh) 2021-05-24 2024-01-05 诺华股份有限公司 用于治疗骨关节炎的方法
CN113683681B (zh) * 2021-09-15 2023-10-03 山西锦波生物医药股份有限公司 一种重组i型人源化胶原蛋白c1l3t及其制备方法和用途
CN113683678B (zh) * 2021-09-15 2023-11-24 山西锦波生物医药股份有限公司 一种重组i型人源化胶原蛋白c1l2t及其制备方法和用途
WO2023084388A1 (en) 2021-11-10 2023-05-19 Novartis Ag Methods for determining the biological activity of angptl polypeptides
CN114377202B (zh) * 2021-12-16 2023-01-24 方向前 适用于软骨再生的功能化自组装miRNA/多肽复合水凝胶及其制备方法
UY40374A (es) 2022-08-03 2024-02-15 Novartis Ag Inhibidores de inflamasoma nlrp3
KR102971681B1 (ko) * 2022-12-09 2026-06-02 (주)케어젠 연골 재생용 펩타이드 및 이의 용도
AU2025220507A1 (en) 2024-02-05 2026-07-23 Novartis Ag Improved production of angptl3 mimetics
WO2026133229A1 (en) 2024-12-20 2026-06-25 Novartis Ag Nlrp3 inflammasome inhibitors

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308236D0 (en) * 1983-03-25 1983-05-05 Celltech Ltd Dna vectors
US5462990A (en) 1990-10-15 1995-10-31 Board Of Regents, The University Of Texas System Multifunctional organic polymers
US5288931A (en) 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
US6447796B1 (en) 1994-05-16 2002-09-10 The United States Of America As Represented By The Secretary Of The Army Sustained release hydrophobic bioactive PLGA microspheres
US6030831A (en) 1997-09-19 2000-02-29 Genetech, Inc. Tie ligand homologues
WO1999055869A1 (en) 1998-04-27 1999-11-04 Zymogenetics, Inc. Novel polypeptide growth factors and materials and methods for making them
EP1078046A4 (en) 1998-05-12 2005-05-11 Human Genome Sciences Inc 97 HUMAN SECRETED PROTEINS
AU4643699A (en) 1998-06-24 2000-01-10 Compugen Ltd. Angiopoietin-like growth factor sequences
JP2003531811A (ja) 1999-03-08 2003-10-28 ジェネンテック・インコーポレーテッド 血管形成及び心臓血管新生の促進又は阻害
WO2000053722A2 (en) 1999-03-10 2000-09-14 Phogen Limited Delivery of nucleic acids and proteins to cells
GB9912350D0 (en) 1999-05-26 1999-07-28 European Molecular Biology Lab Embl Modified cytokine
ATE368110T1 (de) 1999-07-20 2007-08-15 Genentech Inc Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
US20030013649A1 (en) 2000-01-31 2003-01-16 Rosen Craig A. Nucleic acids, proteins, and antibodies
US20030120056A1 (en) 2000-10-16 2003-06-26 Audrey Goddard TIE ligand homologues
AU2437702A (en) 2000-10-16 2002-04-29 Genentech Inc Methods of treatment using wisp polypeptides
US20020130430A1 (en) 2000-12-29 2002-09-19 Castor Trevor Percival Methods for making polymer microspheres/nanospheres and encapsulating therapeutic proteins and other products
US20030027751A1 (en) 2001-04-10 2003-02-06 Genvec, Inc. VEGF fusion proteins
ES2464532T3 (es) 2001-04-19 2014-06-03 The Scripps Research Institute Métodos y composiciones para la producción de pares ortogonales de ARNt-aminoacil-ARNt sintetasa
US20030194798A1 (en) 2001-05-24 2003-10-16 Surber Mark W. Minicell compositions and methods
FI117667B (fi) 2001-07-05 2007-01-15 Univ Zuerich Farmaseuttinen koostumus, joka soveltuu käytettäväksi ortopediassa ja hammaslääketieteessä
KR20100029861A (ko) * 2001-11-16 2010-03-17 제넨테크, 인크. 안지오포이에틴-유사 단백질 3 ａｎｇｐｔｌ3을 함유하는 조성물 및 이를 사용하는 방법
US7060498B1 (en) 2001-11-28 2006-06-13 Genta Salus Llc Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers
US7141540B2 (en) 2001-11-30 2006-11-28 Genta Salus Llc Cyclodextrin grafted biocompatible amphilphilic polymer and methods of preparation and use thereof
JP4764630B2 (ja) 2002-09-09 2011-09-07 ネクター セラピューティックス 水溶性ポリマーアルカナール
EP1558747B1 (en) 2002-10-16 2009-10-14 The Scripps Research Institute Glycoprotein synthesis
MXPA05003983A (es) 2002-10-16 2005-06-22 Scripps Research Inst Incorporacion en sitio especifico de cetoaminoacidos en proteinas.
JP5642916B2 (ja) 2003-04-17 2014-12-17 ザ スクリプス リサーチ インスティテュート 真核遺伝コードの拡張
EP1704242A4 (en) 2003-07-07 2008-06-18 Scripps Research Inst COMPOSITIONS WITH PAIRS OF ORTHOGONAL LEUCYL-TRNA AND AMINOACYL-TRNA-SYNTHETASE AND USES THEREOF
WO2005019415A2 (en) 2003-07-07 2005-03-03 The Scripps Research Institute Compositions of orthogonal lysyl-trna and aminoacyl-trna synthetase pairs and uses thereof
WO2005007624A2 (en) 2003-07-07 2005-01-27 The Scripps Research Institute Compositions of orthogonal glutamyl-trna and aminoacyl trna synthetase pairs and uses thereof
MX2007003142A (es) 2004-09-21 2007-07-04 Scripps Research Inst Incorporacion in vivo de alquinil aminoacidos a proteinas en eubacterias.
MX2007004892A (es) 2004-10-27 2007-08-16 Scripps Research Inst Componentes de traduccion ortogonales para la incorporacion in vivo de aminoacidos no naturales.
AU2006223579A1 (en) 2005-03-11 2006-09-21 Genentech, Inc. Gene disruptions, compositions and methods relating thereto
WO2006127809A2 (en) 2005-05-24 2006-11-30 Whitehead Institute For Biomedical Research Methods for expansion and analysis of cultured hematopoietic stem cells
MX2008011470A (es) 2006-03-09 2008-09-24 Scripps Research Inst Sistemas para la expresion de componentes de traduccion ortogonales en celulas huesped eubacterianas.
KR101460815B1 (ko) 2006-12-06 2014-11-12 세이가가쿠 고교 가부시키가이샤 관절염 질환 치료의 지속성 효과를 갖는 제약 제제
ZA200904022B (en) 2006-12-08 2010-08-25 Lexicon Pharmaceuticals Inc Monoclonal antibodies against ANGPTL3
EP2118150B1 (en) 2007-02-14 2015-09-23 Biocompatibles UK Limited Derivatisation of biological molecules
EP2155862A2 (en) 2007-05-04 2010-02-24 Whitehead Institute For Biomedical Research Ex vivo expansion of human hematopoietic stem cells
PE20160507A1 (es) * 2009-07-14 2016-05-20 Scripps Research Inst Diferenciacion de celulas madre mesenquimales
WO2012106615A1 (en) 2011-02-03 2012-08-09 Xoma Technology Ltd. Methods and materials for enhancing functional protein expression in bacteria
WO2012129562A2 (en) 2011-03-24 2012-09-27 The Scripps Research Institute Compounds and methods for inducing chondrogenesis
US9421245B2 (en) 2012-06-25 2016-08-23 The Brigham And Women's Hospital, Inc. Targeted therapeutics
UY35368A (es) 2013-03-08 2014-10-31 Irm Llc Péptidos y composiciones para el tratamiento de daño articular
US9301971B2 (en) 2013-03-08 2016-04-05 Novartis Ag Peptides and compositions for treatment of joint damage

Similar Documents

Publication Publication Date Title
CN1960758B (zh) 关节炎的治疗剂或预防剂
CN105025917B (zh) 用于治疗关节损坏的肽和组合物
PE20141727A1 (es) Composiciones, usos y metodos para tratamiento de trastornos y enfermedades metabolicas
JP5508275B2 (ja) 骨形態形成タンパク質結合ペプチド
CL2011000013A1 (es) Polipeptido factor estimulante de colonias de granulocitos bovino (bg-csf) que comprende uno o mas aminoacidos no codificados de manera natural; metodo de preparacion; composicion farmaceutica que lo comprende; y su uso para tratar un trastorno modulado por bg-csf.
UY25172A1 (es) Curación de fracturas utilizando análogos pthrp
CN106232153B (zh) 用于移植和组织工程手术的fgf-18
JP2017114909A (ja) 骨修復促進剤
Bab et al. Polypeptide factors regulating osteogenesis and bone marrow repair
US20250345393A1 (en) Isoform nell-1 peptide
US20260008828A1 (en) Regenerative polypeptides and uses thereof
RU2016152151A (ru) Препарат, содержащий фактор viii и пептиды фактора фон виллебранда
US9790264B2 (en) Compounds and methods for modulating pharmacokinetics
CN105658232A (zh) 使用白细胞介素-10治疗疾病和病症的方法
JP6510547B2 (ja) Ｆｇｆ−１８を含むインプラント
CN104903344B (zh) Pedf衍生的多肽在治疗骨关节炎中的用途
WO2016084935A1 (ja) Ｉｉｉ型コラーゲン産生促進剤
US20230010110A1 (en) Histatin-1 formulation for the treatment, repair or regeneration of bone tissue in a subject
JP2019535707A5 (enExample)
CN116603103A (zh) 骨形成促进材料
JP2023530106A (ja) 細胞外マトリックスに結合するＩＬ－１受容体アンタゴニスト（ＩＬ－１Ｒａ）融合タンパク質
JPWO2020085506A1 (ja) 軟骨疾患の治療薬
WO2017221011A1 (en) Treatment of ocular disease
HK40098901A (en) Bone formation promoter
WO2025259915A1 (en) Use of matrix bound nanovesicles (mbv) for inhibition of osteoclasts